A study to determine evolving epidemiology and outcome of PCR-documented SARS-CoV-2 infection in kidney transplant recipients
Latest Information Update: 09 Nov 2022
At a glance
- Drugs Casirivimab/imdevimab (Primary) ; Sotrovimab (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 09 Nov 2022 New trial record